Prasugrel in critically ill patients

While prasugrel is indicated for the treatment of myocardial infarction, its effects in the most severely affected patients requiring intensive care is unknown, so that we measured the antiplatelet effects and sparse pharmacokinetics of prasugrel in critically ill patients. Twenty-three patients adm...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thromb Haemost
Autors principals: Schoergenhofer, Christian, Hobl, Eva-Luise, Staudinger, Thomas, Speidl, Walter S., Heinz, Gottfried, Siller-Matula, Jolanta, Zauner, Christian, Reiter, Birgit, Kubica, Jacek, Jilma, Bernd
Format: Artigo
Idioma:Inglês
Publicat: Schattauer GmbH 2017
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6292180/
https://ncbi.nlm.nih.gov/pubmed/28692105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1160/TH17-03-0154
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars